The tumor microenvironment and the estrogen loop in thyroid cancer
N Denaro, R Romanò, S Alfieri, A Dolci, L Licitra… - Cancers, 2023 - mdpi.com
Simple Summary The composite network of stromal, immune, vascular and cancer cells,
which constitutes the tumor microenvironment (TME), has emerged as a player in thyroid …
which constitutes the tumor microenvironment (TME), has emerged as a player in thyroid …
Multi-omics and management of follicular carcinoma of the thyroid
TE Luvhengo, I Bombil, A Mokhtari, MS Moeng… - Biomedicines, 2023 - mdpi.com
Follicular thyroid carcinoma (FTC) is the second most common cancer of the thyroid gland,
accounting for up to 20% of all primary malignant tumors in iodine-replete areas. The …
accounting for up to 20% of all primary malignant tumors in iodine-replete areas. The …
Association between eight autoimmune diseases and thyroid cancer: a Nationwide Cohort Study
SK Park, JH Ryoo, MH Kim, JY Jung, YS Jung, KN Kim… - Thyroid, 2024 - liebertpub.com
Background: It has often been reported that thyroid-specific autoimmune diseases (ADs),
such as Hashimoto's thyroiditis and Graves' disease, could increase the risk of thyroid …
such as Hashimoto's thyroiditis and Graves' disease, could increase the risk of thyroid …
Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy
M Langouo Fontsa, F Padonou… - Expert Review of …, 2024 - Taylor & Francis
Introduction Tertiary lymphoid structures (TLS) arise at chronic inflammatory sites where they
function as miniature lymph nodes to generate immune responses, which can be beneficial …
function as miniature lymph nodes to generate immune responses, which can be beneficial …
The relationship between thyroid peroxidase antibody and differentiated thyroid cancer: a systematic review and meta-analysis
H Zhang, L Tian, X Wang, X Shi - Frontiers in Endocrinology, 2024 - frontiersin.org
Background Thyroglobulin antibody (TgAb) has been found to be associated with the
occurrence and development of differentiated thyroid cancer (DTC) for several years, but …
occurrence and development of differentiated thyroid cancer (DTC) for several years, but …
Elastographic Evaluation of Thyroid Nodules in Children and Adolescents with Hashimoto's Thyroiditis and Nodular Goiter with Reference to Cytological and/or …
H Borysewicz-Sańczyk, B Sawicka… - Journal of Clinical …, 2022 - mdpi.com
There are data indicating the coexistence of papillary thyroid carcinoma and autoimmune
thyroiditis (AIT) in children. The aim of the study was elastographic evaluation of thyroid …
thyroiditis (AIT) in children. The aim of the study was elastographic evaluation of thyroid …
Selective anti-CXCR2 receptor blockade by AZD5069 inhibits CXCL8-mediated pro-tumorigenic activity in human thyroid cancer cells in vitro
F Coperchini, A Greco, E Petrosino, L Croce… - Journal of …, 2024 - Springer
Background Thyroid cancer is the most common endocrine malignancy. Current therapies
are successful, however some patients progress to therapeutically refractive disease. The …
are successful, however some patients progress to therapeutically refractive disease. The …
Germline polymorphisms of the NOD2 pathway may predict the effectiveness of radioiodine in differentiated thyroid cancer treatment
M Borowczyk, M Kaczmarek-Ryś… - Journal of …, 2024 - Springer
Purpose Differentiated thyroid cancer (DTC) presents a complex clinical challenge,
especially in patients with distant metastases and resistance to standard treatments. This …
especially in patients with distant metastases and resistance to standard treatments. This …
FDG uptake reflects an immune‐enriched subtype of thyroid cancer: Clinical implications of imaging‐based molecular characterization
Introduction Iodine and FDG uptakes have been established as methods to define the
biological properties of thyroid cancer. As various cells in the tumor microenvironment (TME) …
biological properties of thyroid cancer. As various cells in the tumor microenvironment (TME) …
Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?
F Padonou, T Vanhulst… - Current Opinion in …, 2024 - journals.lww.com
Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy
response in melanoma? Page 1 CURRENT OPINION Can we yet use tertiary lymphoid structures …
response in melanoma? Page 1 CURRENT OPINION Can we yet use tertiary lymphoid structures …